Clinical Trials Logo
  1. Home
  2. Dry Eye Syndromes
  3. NCT04744805
  4. Details
NCT04744805 Clinical Trial

Mask-associated Dry Eye Symptoms in China

Dry Eye Syndromes Clinical Trial

Official title:
Mask-associated Dry Eye Symptoms: an Online Survey of 6262 Chinese Persons

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04744805
Other study ID # 2021003
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 29, 2021
Est. completion date February 6, 2021

Study information
Verified date February 2021
Source Tianjin Eye Hospital
Contact Yan Wang, director
Phone +862227313336
Email wangyan7143@vip.sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To review the relationship of increased face mask usage arising from lockdown measures instituted during the COVID-19 pandemic with dry eye symptoms on Chinese people, and make recommendations for mitigating potential detrimental effects on dry eye symptoms.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 6262
Est. completion date February 6, 2021
Est. primary completion date February 5, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 80 Years
Eligibility Inclusion Criteria: - age >=8 years mental health Exclusion Criteria: - eye diseases mental or systemic diseases

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• face mask or not
long term face mask wear

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Tianjin Eye Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary time of face mask wear 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Not yet recruiting NCT06379685 - Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. Phase 1
Recruiting NCT04701086 - 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis N/A
Active, not recruiting NCT03697876 - Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel Phase 1
Terminated NCT02815293 - Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye Phase 3
Completed NCT02910713 - Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation N/A
Completed NCT04104997 - A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers Phase 1
Recruiting NCT02595606 - 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients Phase 4
Completed NCT01711424 - An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease N/A
Completed NCT01015209 - Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers Phase 1
Completed NCT01202747 - Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction Phase 2/Phase 3
Completed NCT00969280 - Acupuncture for Dry Eye Syndrome Phase 3
Completed NCT01496482 - Comparison of Evaporimetry With the Established Methods of Tear Film Measurement N/A
Completed NCT00756678 - Efficacy and Acceptability of Two Lubricant Eye Drops Phase 4
Completed NCT00739713 - Effects of Sea Buckthorn Oil on Dry Eye N/A
Completed NCT00370747 - Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome Phase 2
Completed NCT00349440 - Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy Phase 4
Completed NCT05162261 - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction N/A
Completed NCT02871440 - A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye Phase 3
Completed NCT05042960 - Computer Screen Properties Study N/A